Regentis Biomaterials Ord Shs
RGNT7.100USD
0.000
Market hours （ET）Quotes delayed by 15 min
--Market Cap
--P/E TTM
More Details of Regentis Biomaterials Ord Shs Company
Regentis Biomaterials Ltd is an Israel-based regenerative medicine company. The Company is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Its lead product is GellinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage. Its implant combines the precision of photopolymerization with the biocompatibility of PEG and fibrinogen, enabling natural tissue regeneration without the need for cell harvesting or culturing. Regentis Biomaterials Ltd aims to address unmet clinical needs in sports medicine and early-stage osteoarthritis.
Regentis Biomaterials Ord Shs Info
Ticker SymbolRGNT
Company nameRegentis Biomaterials Ltd
IPO dateDec 04, 2025
CEOHazum (Eli)
Number of employees- -
Security typeOrdinary Share
Fiscal year-end- -
Address60, Medinat Hyahudim
CityHERZLIYA
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryIsrael
Postal code4676652
Phone97246265502
Websitehttps://www.regentis.co.il/
Ticker SymbolRGNT
IPO dateDec 04, 2025
CEOHazum (Eli)
Company Executives of Regentis Biomaterials Ord Shs
Name
Name/Position
Position
Shareholding
Change
Dr. Susan Alpert, M.D., Ph.D.
Dr. Susan Alpert, M.D., Ph.D.
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Pini Ben-Elazar
Mr. Pini Ben-Elazar
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Efraim Cohen-Arazi
Mr. Efraim Cohen-Arazi
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Catherine C. (Keith) Valentine
Mr. Catherine C. (Keith) Valentine
Independent Director
Independent Director
--
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Arie Gordashnikov, CPA
Mr. Arie Gordashnikov, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jeff Dykan, CPA
Mr. Jeff Dykan, CPA
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Susan Alpert, M.D., Ph.D.
Dr. Susan Alpert, M.D., Ph.D.
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Pini Ben-Elazar
Mr. Pini Ben-Elazar
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Efraim Cohen-Arazi
Mr. Efraim Cohen-Arazi
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Catherine C. (Keith) Valentine
Mr. Catherine C. (Keith) Valentine
Independent Director
Independent Director
--
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Executive Officer
Chief Executive Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Reporting Period
No. of institutions
Shares Held
Proportion
Change
No Data
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Regentis Biomaterials Ord Shs?
The top five shareholders of Regentis Biomaterials Ord Shs are:
What are the top three shareholder types of Regentis Biomaterials Ord Shs?
The top three shareholder types of Regentis Biomaterials Ord Shs are:
Other
Other
How many institutions hold shares of Regentis Biomaterials Ord Shs (RGNT)?
As of --, -- institutions hold shares of Regentis Biomaterials Ord Shs, with a combined market value of approximately --, accounting for --% of the total shares. Compared to --, institutional shareholding has increased by --.
What is the biggest source of revenue for Regentis Biomaterials Ord Shs?
In --, the -- business generated the highest revenue for Regentis Biomaterials Ord Shs, amounting to -- and accounting for --% of total revenue.
